Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
12.18
+0.33 (2.78%)
At close: Aug 22, 2025, 4:00 PM
12.39
+0.21 (1.72%)
After-hours: Aug 22, 2025, 6:34 PM EDT
Greenwich LifeSciences Employees
As of December 31, 2024, Greenwich LifeSciences had 8 total employees, including 4 full-time and 4 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,249,072
Market Cap
166.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8 | 1 | 14.29% |
| Dec 31, 2023 | 7 | 1 | 16.67% |
| Dec 31, 2022 | 6 | 0 | - |
| Dec 31, 2021 | 6 | 3 | 100.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GLSI News
- 3 days ago - Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences - GlobeNewsWire
- 4 days ago - Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team - GlobeNewsWire
- 10 days ago - Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania - GlobeNewsWire
- 12 days ago - Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events - GlobeNewsWire
- 5 months ago - Greenwich LifeSciences Provides Global Update on FLAMINGO-01 - GlobeNewsWire
- 5 months ago - Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial - GlobeNewsWire
- 5 months ago - Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026 - GlobeNewsWire
- 5 months ago - Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01 - GlobeNewsWire